deucravacitinib
bms
['#1117', 'deucra']
pike et al. deucravactinib (tyk2i) in sle. + on sri(4) week 32. + sri(4),bicla, lldas, clasi-50, swollen and tender joint counts week 48. strange, the lowest dose (3mg bd) seems best. #acr22 abstr#1117 #acrbest 
Rheumatologist @stjamesdublin , Associate Professor @tcddublin , Acute Medicine, Vasculitis, ILD, Retired @Emeunet Executive Committee member, @rheum_covid CASC